Antistius mV Table n / a film about prolong. 35mg 60 pc

Description

Composition
Active substance:
1 tablet contains: trimetazidine dihydrochloride – 35 mg.
Product form:
Prolonged action tablets, film-coated 35mg. 10, 20, 30 tablets were placed in blisters of PVC film and aluminum foil printed patent. 10, 20, 30, 40, 50, 60 or 100 tablets were placed in a polymeric container for medicines. One container or 1, 2, 3, 4, 5, 6 or 10, the contour of cellular packaging together with instructions for use placed in a pile of cardboard.
Contraindications
– Hypersensitivity to any component of the drug; – renal failure (creatinine clearance less than 15 mL / min); – expressed human liver; – the age of 18 years (effectiveness and safety have been established).
Dosage
35 mg
Indications
Ischemic heart disease: prevention of angina attacks (in the complex therapy). Kohleovestibulyarny violations ischemic nature, such as vertigo, tinnitus, hearing loss. Chorioretinal vascular disorders.
pharmachologic effect
Pharmacological group:
Antihypoxanth means. ATC code S01EV15.
Pharmacological properties:
It provides anti-hypoxic action. Directly affecting the cardiomyocytes and neurons in the brain, the drug to optimize their metabolism and function. Cytoprotective effect is due to an increase in potential energy, the activation of the oxidative decarboxylation and the rationalization of oxygen consumption (increased glycolysis and fatty acid oxidation blockade). Trimetazidine supports myocardial contractility, prevents the decrease in intracellular adenosine triphosphate (ATP) and phosphocreatine. In acidosis conditions normalize the functioning of ionic channels membranes, prevents the accumulation of calcium ions and PRODUCER Ltd. “Ozone” sodium in cardiomyocytes normalizes the intracellular content of potassium ions. Reduces intracellular acidosis and increased phosphate content, due to myocardial ischemia and reperfusion. Prevents the damaging action of free radicals, preserves the integrity of cellular membranes, prevents activation of neutrophils in the ischemic area, increases the electrical potential, reduces yield creatine kinase (CK) cells and the severity of ischemic myocardial injury. Trimetazidine reduces the frequency of angina attacks, reduce the need for taking nitrates, after 2 weeks of treatment improves exercise capacity, reduced blood pressure sharp fluctuations (BP). Reduces dizziness and tinnitus ischemic etiology. When vascular eye disease restores the function The activity of the retina.
Conditions of supply of pharmacies
Prescription.
Dosing and Administration
Inside, during a meal. Antistius CF prescribed 1 tablet 2 times a day (morning and evening). The course of treatment – on the advice of a doctor.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist